The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–289 of 289
Characterization of ochratoxin A transport by human organic anion transporters
Jung, K. Y., Takeda, M., Kim, D. K., Tojo, A., Narikawa, S., Yoo, B. S., Hosoyamada, M., Ho, S., Sekine, T., & Endou, H. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01296-6 · Cited by 114
Takeda, M., Narikawa, S., Hosoyamada, M., Ho, S., Sekine, T., & Endou, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00962-1 · Cited by 111
Niemi, M., Arnold, K. A., Backman, J. T., Pasanen, M. K., Gödtel‐Armbrust, U., Wojnowski, L., Zanger, U. M., Neuvonen, P. J., Eichelbaum, M. F., Kivistö, K. T., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230422.50962.91 · Cited by 109
Higgins, J. W., Bedwell, D. W., & Zamek‐Gliszczynski, M. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.044875 · Cited by 108
Fahrmayr, C., Fromm, M. F., & König, J. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491683 · Cited by 108
Self-citationIto, S., Kusuhara, H., Kumagai, Y., Moriyama, Y., Inoue, K., Kondo, T., Nakayama, H., Horita, S., Tanabe, K., Yuasa, H., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.138 · Cited by 108
Oswald, S., Haenisch, S., Fricke, C., Sudhop, T., Remmler, C., Gießmann, T., Jedlitschky, G., Adam, U., Dazert, E., Warzok, R., et al. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.11.004 · Cited by 108
Ciarimboli, G., Holle, S. K., Vollenbröcker, B., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100329u · Cited by 107
Kindla, J., Müller, F., Mieth, M., Fromm, M. F., & König, J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037622 · Cited by 106
Self-citationDrug interactions with herbal products and grapefruit juice: a conference report
Huang, S. M., Hall, S. D., Watkins, P., Love, L. A., Serabjit-Singh, C., Betz, J. M., Hoffman, F. A., Honig, P., Coates, P. M., Bull, J., et al. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.07.002 · Cited by 106
Loss of analgesic effect of morphine due to coadministration of rifampin
Fromm, M. F., Eckhardt, K., Li, S., et al. (1997) · Pain · doi:10.1016/s0304-3959(97)00044-4 · Cited by 104
Self-citationRost, D., König, J., Weiß, G., Klar, E., Stremmel, W., & KEPPLER, D. O. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28648 · Cited by 101
Self-citationTransporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions
Zolk, O., & Fromm, M. F. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.354 · Cited by 101
Self-citationIgel, M., Sudhop, T., & von Bergmann, K. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102731 · Cited by 100
zu Schwabedissen, H. E. M., & Kroemer, H. K. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_9 · Cited by 99
Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy
Pauli‐Magnus, C., Meier, P. J., & Stieger, B. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253224 · Cited by 96
EXPRESSION OF CYP3A ISOFORMS AND P‐GLYCOPROTEIN IN HUMAN STOMACH, JEJUNUM AND ILEUM
Canaparo, R., Finnström, N., Serpe, L., Nordmark, A., Muntoni, E., Eandi, M., Rane, A., & Zara, G. P. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04691.x · Cited by 96
Iwata, K., Aizawa, K., Kamitsu, S., Jingami, S., Fukunaga, E., Yoshida, M., Yoshimura, M., Hamada, A., & Saito, H. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0638-y · Cited by 95
Methotrexate-Loxoprofen Interaction: Involvement of Human Organic Anion Transporters hOAT1 and hOAT3
Uwai, Y., Taniguchi, R., Motohashi, H., Saito, H., Okuda, M., & Inui, K. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.369 · Cited by 94
Feng, B., Obach, R., Burstein, A., Clark, D., de Morais, S., & Faessel, H. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100405 · Cited by 93
Hedman, M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.011 · Cited by 93
Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren
Tapaninen, T., Neuvonen, P. J., & Niemi, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03898.x · Cited by 92
Ma, Z., Zhang, Y., Huet, P., & Lee, S. S. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80109-3 · Cited by 92
Barnouin, K., Leier, I., Jedlitschky, G., Pourtier, A., König, J., Lehmann, W., & KEPPLER, D. O. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.34 · Cited by 91
Self-citationInterplay of Transporters and Enzymes in Drug and Metabolite Processing
Pang, K. S., Maeng, H., & Fan, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900258z · Cited by 91
VanWert, A. L., Bailey, R. M., & Sweet, D. H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00319.2007 · Cited by 91
Single‐ and multiple‐dose pharmacokinetics of bosentan and its interaction with ketoconazole
van Giersbergen, P. L. M., Halabi, A., & Dingemanse, J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01608.x · Cited by 89
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
He, Y., Zhang, W., Chen, Y., Guo, D., Tu, J., Xu, L., Tan, Z., Chen, B., Li, Z., Zhou, G., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.04.003 · Cited by 88
Shitara, Y., Takeuchi, K., Nagamatsu, Y., Wada, S., Sugiyama, Y., & Horie, T. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-096 · Cited by 87
Takano, A., Kusuhara, H., Suhara, T., Ieiri, I., Morimoto, T., Lee, Y. J., Maeda, J., Ikoma, Y., Ito, H., Suzuki, K., et al. (2006) · PubMed · Cited by 86
van der Heijden, J., de Jong, M. C., Dijkmans, B. A. C., Lems, W. F., Oerlemans, R., Kathmann, I., Schalkwijk, C. G., Scheffer, G. L., Scheper, R. J., & Jansen, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.005249 · Cited by 85
McConn, D. J., Lin, Y. S., Allen, K. E., Kunze, K. L., & Thummel, K. E. (2004) · PubMed · doi:10.1124/dmd.32.10 · Cited by 85
Kalliokoski, A., Backman, J. T., Kurkinen, K. J., Neuvonen, P. J., & Niemi, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.74 · Cited by 84
Dahan, A., & Amidon, G. L. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9789-7 · Cited by 84
Vlaming, M. L. H., van Esch, A., Pala, Z., Wagenaar, E., van de Wetering, K., van Tellingen, O., & Schinkel, A. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0668 · Cited by 83
Cho, S. K., Yoon, J. S., Lee, M. G., Lee, D. H., Lim, L. A., Park, K., Park, M. S., & Chung, J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.266 · Cited by 82
Scheen, A. J. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746020-00001 · Cited by 81
The Contribution of Organic Anion Transporters OAT1 and OAT3 to the Renal Uptake of Rosuvastatin
Windass, A. S., Lowes, S., Wang, Y., & Brown, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125831 · Cited by 81
Effect of quinidine on digoxin bioavailability
Pedersen, K. E., Christiansen, B. D., Klitgaard, N. A., & Nielsen‐Kudsk, F. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613925 · Cited by 78
Transporter-Mediated Drug–Drug Interactions
Zhang, L., Sm, H., & Lesko, L. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.359 · Cited by 78
Neuhofel, A. L., Wilton, J. H., Victory, J. M., Hejmanowski, L. G., & Amsden, G. W. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011391 · Cited by 77
Cihlář, T., & Ho, E. S. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4633 · Cited by 77
Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
Cascorbi, I., & Haenisch, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_6 · Cited by 75
Igel, S., Drescher, S., rdter, T. E. M., Hofmann, U., Heinkele, G., Tegude, H., Glaeser, H., Brenner, S. S., Somogyi, A. A., Omari, T. I., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746090-00005 · Cited by 72
Self-citationInteractions of Human- and Rat-Organic Anion Transporters With Pravastatin and Cimetidine
Khamdang, S., Takeda, M., Shimoda, M., Noshiro, R., Narikawa, S., Huang, X.-L., Enomoto, A., Piyachaturawat, P., & Endou, H. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.197 · Cited by 71
Disposition of metformin: Variability due to polymorphisms of organic cation transporters
Zolk, O. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.549144 · Cited by 71
Aging and renal clearance of procainamide and acetylprocainamide
Reidenberg, M. M., Camacho, M. T., Kluger, J., & Drayer, D. E. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.228 · Cited by 71
Nakagomi, R., Nakai, D., & Tokui, T. (2007) · Xenobiotica · doi:10.1080/00498250601188808 · Cited by 70
Shirasaka, Y., Suzuki, K., Shichiri, M., Nakanishi, T., & Tamai, I. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rg-073 · Cited by 69
Abel, S., Nichols, D. J., Brearley, C. J., & Eve, M. D. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00114.x · Cited by 68
Rebello, S. S., Zhao, S., Hariry, S., Dahlke, M., Alexander, N., Vapurcuyan, A., Hanna, I. H., & Jarugula, V. R. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1167-4 · Cited by 67
Fan, J., Chen, S., Chow, E. C. Y., & Pang, K. S. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328931 · Cited by 67
Lee, W.-K., Reichold, M., Edemir, B., Ciarimboli, G., Warth, R., Koepsell, H., & Thévenod, F. (2009) · AJP - Renal Physiology · doi:10.1152/ajprenal.90754.2008 · Cited by 65
Molecular Mechanisms of Drug Transporter Regulation
Tirona, R. G. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_10 · Cited by 64
Fahrmayr, C., König, J., Auge, D., Mieth, M., & Fromm, M. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01672.x · Cited by 64
Self-citationHuman intestinal P‐glycoprotein activity estimated by the model substrate digoxin
Larsen, U. L., Olesen, H. L., Nyvold, C. G., Eriksen, J., Jakobsen, P., Østergaard, M., Autrup, H. N., & Andersen, V. C. (2006) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510600986084 · Cited by 63
Quinidine reduces biliary clearance of digoxin in man
Angelin, B., Arvidsson, A., Dahlqvist, R., Hedman, A., & Schenck-Gustafsson, K. G. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01246.x · Cited by 62
Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion‐Transporting Polypeptides
Greenblatt, D. J. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009342251 · Cited by 62
Damme, K., Nies, A. T., Schaeffeler, E., & Schwab, M. G. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.602687 · Cited by 60
Paine, M. F., Widmer, W., Pusek, S. N., Beavers, K. L., Criss, A. B., Snyder, J. A., & Watkins, P. B. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.863 · Cited by 60
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A*
Park, J. W., Siekmeier, R., Merz, M., Krell, B., Harder, S., März, W., Seidel, D., Schüler, S., & Groß, W. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40439 · Cited by 60
Sissung, T. M., Troutman, S. M., Campbell, T. J., Pressler, H. M., Sung, H., Bates, S. E., & Figg, W. D. (2012) · PubMed · Cited by 58
Renal drug–drug interactions: what we have learned and where we are going
Lepist, E., & Ray, A. S. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.667401 · Cited by 57
Stereoselective inhibition of pindolol renal clearance by cimetidine in humans
Somogyi, A. A., Bochner, F., & Sallustio, B. C. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.37 · Cited by 56
Hays, A. L., Apte, U. M., & Hagenbuch, B. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0962-7 · Cited by 55
SLCO1B1Genetic Polymorphism Influences Mycophenolic Acid Tolerance in Renal Transplant Recipients
Michelon, H., König, J., Dürrbach, A., Quteineh, L., Verstuyft, C., Furlan, V., Ferlicot, S., Letierce, A., Charpentier, B., Fromm, M. F., et al. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.132 · Cited by 54
Self-citationTrimethoprim alters the disposition of procainamide and N-acetylprocainamide
Kosoglou, T., Rocci, M. L., & Vlasses, P. H. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.181 · Cited by 51
Interaction of beta‐blockers with the renal uptake transporter OCT2
Bachmakov, I., Glaeser, H., Endreß, B., Mörl, F., König, J., & Fromm, M. F. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01076.x · Cited by 50
Self-citationCha, P.-C., Mushiroda, T., Zembutsu, H., Harada, H., Shinoda, N., Kawamoto, S., Shimoyama, R., Nishidate, T., Furuhata, T., Sasaki, K., et al. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.80 · Cited by 50
Cimetidine Reduces Procainamide Elimination
Somogyi, A. A., & Heinzow, B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071715 · Cited by 46
Lockhart, A. C. (2008) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s3743 · Cited by 43
Influence of Dietary Substances on Intestinal Drug Metabolism and Transport
Won, C. S., Oberlies, N. H., & Paine, M. F. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328869 · Cited by 43
Interaction of innovative small molecule drugs used for cancer therapy with drug transporters
Mandery, K., Glaeser, H., & Fromm, M. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01618.x · Cited by 42
Self-citationWallace, A. W., Victory, J. M., & Amsden, G. W. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003253399 · Cited by 41
Oswald, S., Terhaag, B., & Siegmund, W. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_11 · Cited by 39
Umehara, K., Iwatsubo, T., Noguchi, K., Usui, T., & Kamimura, H. (2008) · Xenobiotica · doi:10.1080/00498250802334409 · Cited by 39
Torasemide Transport by Organic Anion Transporters Contributes to Hyperuricemia
Hagos, Y., Bahn, A., Vormfelde, S. V., Diaeresis]ller, J. D. B., & Burckhardt, G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010106 · Cited by 38
Renal Organic Anion Transporter-Mediated Drug-Drug Interaction between Gemcabene and Quinapril
Yuan, H., Feng, B., Yu, Y., Chupka, J., Zheng, J. Y., Heath, T. G., & Bond, B. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149476 · Cited by 37
Cisapride-Cimetidine Interaction
Kirch, W., Janisch, H. D., Ohnhaus, E. E., et al. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198907000-00007 · Cited by 33
Yabuuchi, H., Tanaka, K. A. K., Maeda, M., Takemura, M., Oka, M., Ohashi, R., & Tamai, I. (2008) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.629 · Cited by 31
Tubular transporters and clearance of adefovir
Servais, A., Lechat, P. P., Zahr, N., Urien, S., Aymard, G., Jaudon, M. C., Deray, G., & Bagnis, C. I. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.047 · Cited by 30
Fahrmayr, C., König, J., Auge, D., Mieth, M., Münch, K., Segrestaa, J., Pfeifer, T., Treiber, A., & Fromm, M. F. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12126 · Cited by 28
Self-citationDrug transport by breast cancer resistance protein
Poguntke, M., Hazai, E., Fromm, M. F., & Zolk, O. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.519700 · Cited by 27
Self-citationzu Schwabedissen, H. E. M., Ware, J. A., Finkelstein, D., Chaudhry, A. S., Mansell, S. E., Leon‐Ponte, M., Strom, S. C., Zaher, H., Schwarz, U. I., Freeman, D. J., et al. (2011) · Hepatology · doi:10.1002/hep.24391 · Cited by 27
Hesperidin in orange juice reduces the absorption of celiprolol in rats
Uesawa, Y., & Mohri, K. (2008) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.603 · Cited by 26
Klatt, S., Fromm, M. F., & König, J. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12031 · Cited by 22
Self-citationHashimoto, T., Narikawa, S., Huang, X.-L., Minematsu, T., Usui, T., Kamimura, H., & Endou, H. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.10.1096 · Cited by 20
Kawata, S. (2008) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-008-0001-8 · Cited by 13
Vree, T. B., van den Biggelaar-Martea, M., & Wissen, C. P. W. G. M. V.-V. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb03278.x · Cited by 7
Cited by
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
Fattorusso, A., Matricardi, S., Mencaroni, E., Dell'Isola, G. B., Di Cara, G., Striano, P., & Verrotti, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.674483 · Cited by 269
Drozdzik, M., Gröer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y., Prasad, B., Unadkat, J. D., Siegmund, W., & Oswald, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500330y · Cited by 258
Metadata
- Authors
- König, J., Müller, F., & Fromm, M. F.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 65
- Issue
- 3
- Pages
- 944-966
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2098118571
- Cited by
- 575
- References
- 289
- FWCI
- 26.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.